Publications Authored by Christopher C Nolan

Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer.

Breast Cancer Res Treat 2019 Jul 2;176(1):63-73. Epub 2019 Apr 2.

Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1007/s10549-019-05216-w	DOI Listing

July 2019

The combined expression of solute carriers is associated with a poor prognosis in highly proliferative ER+ breast cancer.

Authors:

Rokaya El-Ansari Madeleine L Craze Lutfi Alfarsi Daniele Soria Maria Diez-Rodriguez Christopher C Nolan Ian O Ellis Emad A Rakha Andrew R Green

Breast Cancer Res Treat 2019 May 22;175(1):27-38. Epub 2019 Jan 22.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1007/s10549-018-05111-w	DOI Listing

May 2019

SHON expression predicts response and relapse risk of breast cancer patients after anthracycline-based combination chemotherapy or tamoxifen treatment.

Br J Cancer 2019 Apr 28;120(7):728-745. Epub 2019 Feb 28.

The Institute of Genetics and Cytology, Northeast Normal University, Changchun, China.

View Article

Download full-text PDF	Source
http://www.nature.com/articles/s41416-019-0405-x	Publisher Site
http://dx.doi.org/10.1038/s41416-019-0405-x	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461947	PMC

April 2019

Glutamate dehydrogenase (GLUD1) expression in breast cancer.

Authors:

Madeleine L Craze Rokaya El-Ansari Mohammed A Aleskandarany Kiu Wai Cheng Lutfi Alfarsi Brendah Masisi Maria Diez-Rodriguez Christopher C Nolan Ian O Ellis Emad A Rakha Andrew R Green

Breast Cancer Res Treat 2019 Feb 23;174(1):79-91. Epub 2018 Nov 23.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1007/s10549-018-5060-z	DOI Listing

February 2019

Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer.

Authors:

Lutfi H Alfarsi Rokaya Elansari Michael S Toss Maria Diez-Rodriguez Christopher C Nolan Ian O Ellis Emad A Rakha Andrew R Green

Breast Cancer Res Treat 2019 Jan 10;173(1):93-102. Epub 2018 Oct 10.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF	Source
http://link.springer.com/10.1007/s10549-018-4978-5	Publisher Site
http://dx.doi.org/10.1007/s10549-018-4978-5	DOI Listing

January 2019

Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance.

Authors:

Maryam Althobiti Mohammed A Aleskandarany Chitra Joseph Michael Toss Nigel Mongan Maria Diez-Rodriguez Christopher C Nolan Ibraheem Ashankyty Ian O Ellis Andrew R Green Emad A Rakha

Histopathology 2018 Dec 9;73(6):887-896. Epub 2018 Oct 9.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1111/his.13695	DOI Listing

December 2018

Thioredoxin-interacting protein is an independent risk stratifier for breast ductal carcinoma in situ.

Authors:

Islam M Miligy Kylie L Gorringe Michael S Toss Abdulbaqi A Al-Kawaz Peter Simpson Maria Diez-Rodriguez Christopher C Nolan Ian O Ellis Andrew R Green Emad A Rakha

Mod Pathol 2018 12 28;31(12):1807-1815. Epub 2018 Jun 28.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1038/s41379-018-0086-7	DOI Listing

December 2018

Saccharomyces cerevisiae-like 1 (SEC14L1) is a prognostic factor in breast cancer associated with lymphovascular invasion.

Authors:

Sultan N Sonbul Mohammed A Aleskandarany Sasagu Kurozumi Chitra Joseph Michael S Toss Maria Diez-Rodriguez Christopher C Nolan Abhik Mukherjee Stewart Martin Carlos Caldas Ian O Ellis Andrew R Green Emad A Rakha

Mod Pathol 2018 11 28;31(11):1675-1682. Epub 2018 Jun 28.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1038/s41379-018-0092-9	DOI Listing

November 2018

Clinicopathological and prognostic significance of Ras association and pleckstrin homology domains 1 (RAPH1) in breast cancer.

Authors:

Sasagu Kurozumi Chitra Joseph Sultan Sonbul Mohammed A Aleskandarany Marian Pigera Mansour Alsaleem Sami Alsaeed Yousif Kariri Christopher C Nolan Maria Diez-Rodriguez Simon Johnston Nigel P Mongan Takaaki Fujii Ken Shirabe Stewart G Martin Ian O Ellis Andrew R Green Emad A Rakha

Breast Cancer Res Treat 2018 Nov 28;172(1):61-68. Epub 2018 Jul 28.

Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF	Source
http://link.springer.com/10.1007/s10549-018-4891-y	Publisher Site
http://dx.doi.org/10.1007/s10549-018-4891-y	DOI Listing

November 2018

Clinical and biological roles of Kelch-like family member 7 in breast cancer: a marker of poor prognosis.

Authors:

Sasagu Kurozumi Chitra Joseph Sultan Sonbul Kylie L Gorringe Marian Pigera Mohammed A Aleskandarany Maria Diez-Rodriguez Christopher C Nolan Takaaki Fujii Ken Shirabe Hiroyuki Kuwano Sarah Storr Stewart G Martin Ian O Ellis Andrew R Green Emad A Rakha

Breast Cancer Res Treat 2018 Aug 9;170(3):525-533. Epub 2018 Apr 9.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1007/s10549-018-4777-z	DOI Listing

August 2018

The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes.

Authors:

Rokaya El Ansari Madeleine L Craze Maria Diez-Rodriguez Christopher C Nolan Ian O Ellis Emad A Rakha Andrew R Green

Br J Cancer 2018 04 16;118(8):1115-1122. Epub 2018 Mar 16.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1038/s41416-018-0038-5	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931111	PMC

April 2018

Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes.

Authors:

Chitra Joseph Olivia Macnamara Madeleine Craze Roslin Russell Elena Provenzano Christopher C Nolan Maria Diez-Rodriguez Sultan N Sonbul Mohammed A Aleskandarany Andrew R Green Emad A Rakha Ian O Ellis Abhik Mukherjee

Br J Cancer 2018 04 28;118(8):1142-1151. Epub 2018 Mar 28.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1038/s41416-018-0041-x	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931067	PMC

April 2018

The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours.

Authors:

Rokaya El Ansari Madeleine L Craze Islam Miligy Maria Diez-Rodriguez Christopher C Nolan Ian O Ellis Emad A Rakha Andrew R Green

Breast Cancer Res 2018 03 22;20(1):21. Epub 2018 Mar 22.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1186/s13058-018-0946-6	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863851	PMC

March 2018

MYC regulation of glutamine-proline regulatory axis is key in luminal B breast cancer.

Authors:

Madeleine L Craze Hayley Cheung Natasha Jewa Nuno D M Coimbra Daniele Soria Rokaya El-Ansari Mohammed A Aleskandarany Kiu Wai Cheng Maria Diez-Rodriguez Christopher C Nolan Ian O Ellis Emad A Rakha Andrew R Green

Br J Cancer 2018 01 23;118(2):258-265. Epub 2017 Nov 23.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK.

View Article

Download full-text PDF	Source
http://www.nature.com/doifinder/10.1038/bjc.2017.387	Publisher Site
http://dx.doi.org/10.1038/bjc.2017.387	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785743	PMC

January 2018

Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ.

Authors:

Islam Miligy Priya Mohan Ahmed Gaber Mohammed A Aleskandarany Christopher C Nolan Maria Diez-Rodriguez Abhik Mukherjee Caroline Chapman Ian O Ellis Andrew R Green Emad A Rakha

Histopathology 2017 Aug 26;71(2):258-268. Epub 2017 May 26.

Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1111/his.13217	DOI Listing

August 2017

Phenotypic characterisation of breast cancer: the role of CDC42.

Authors:

Eleni Chrysanthou Kylie L Gorringe Chitra Joseph Madeleine Craze Christopher C Nolan Maria Diez-Rodriguez Andrew R Green Emad A Rakha Ian O Ellis Abhik Mukherjee

Breast Cancer Res Treat 2017 Jul 27;164(2):317-325. Epub 2017 Apr 27.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1007/s10549-017-4267-8	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487723	PMC

July 2017

Further evidence to support bimodality of oestrogen receptor expression in breast cancer.

Authors:

Abir A Muftah Mohammed Aleskandarany Sultan N Sonbul Christopher C Nolan Maria Diez Rodriguez Carlos Caldas Ian O Ellis Andrew R Green Emad A Rakha

Histopathology 2017 Feb 28;70(3):456-465. Epub 2016 Nov 28.

Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1111/his.13089	DOI Listing

February 2017

MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours.

Authors:

Andrew R Green Mohammed A Aleskandarany Devika Agarwal Somaia Elsheikh Christopher C Nolan Maria Diez-Rodriguez R Douglas Macmillan Graham R Ball Carlos Caldas Srinivasan Madhusudan Ian O Ellis Emad A Rakha

Br J Cancer 2016 Apr 8;114(8):917-28. Epub 2016 Mar 8.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1038/bjc.2016.46	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984797	PMC

April 2016

The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts.

Authors:

Mohammed A Aleskandarany Devika Agarwal Ola H Negm Graham Ball Ahmed Elmouna Ibraheem Ashankyty Edem Nuglozeh Mohammad F Fazaludeen Maria Diez-Rodriguez Christopher C Nolan Patrick J Tighe Andrew R Green Ian O Ellis Emad A Rakha

Breast Cancer Res Treat 2016 Feb 23;156(1):9-20. Epub 2016 Feb 23.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1007/s10549-016-3709-z	DOI Listing

February 2016

Clinical utility of reverse phase protein array for molecular classification of breast cancer.

Authors:

Ola H Negm Abir A Muftah Mohammed A Aleskandarany Mohamed R Hamed Dena A J Ahmad Christopher C Nolan Maria Diez-Rodriguez Patrick J Tighe Ian O Ellis Emad A Rakha Andrew R Green

Breast Cancer Res Treat 2016 Jan 9;155(1):25-35. Epub 2015 Dec 9.

Department of Histopathology, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF	Source
http://link.springer.com/content/pdf/10.1007%2Fs10549-015-36	Web Search
http://link.springer.com/10.1007/s10549-015-3654-2	Publisher Site
http://dx.doi.org/10.1007/s10549-015-3654-2	DOI Listing

January 2016

Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series.

Authors:

Andrew R Green Daniele Soria Jacqueline Stephen Desmond G Powe Christopher C Nolan Ian Kunkler Jeremy Thomas Gillian R Kerr Wilma Jack David Cameron Tammy Piper Graham R Ball Jonathan M Garibaldi Emad A Rakha John Ms Bartlett Ian O Ellis

J Pathol Clin Res 2016 Jan 15;2(1):32-40. Epub 2016 Jan 15.

Division of Cancer and Stem CellsBreast Cancer Pathology Research Group, School of Medicine, University of Nottingham, Nottingham City HospitalHucknall RoadNottinghamNG5 1PB; Cellular Pathology, Nottingham University Hospitals NHS TrustHucknall RoadNottinghamNG5 1PB.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1002/cjp2.32	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858129	PMC

January 2016

Biological characteristics and clinical outcome of triple negative primary breast cancer in older women - comparison with their younger counterparts.

Authors:

Binafsha M Syed Andrew R Green Christopher C Nolan David A L Morgan Ian O Ellis Kwok-Leung Cheung

PLoS One 2014 7;9(7):e100573. Epub 2014 Jul 7.

School of Medicine, University of Nottingham, Nottingham, United Kingdom.

View Article

Download full-text PDF	Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0100573	PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085072	PMC

February 2015

DNA damage response markers are differentially expressed in BRCA-mutated breast cancers.

Authors:

Mohammed Aleskandarany Daniela Caracappa Christopher C Nolan R Douglas Macmillan Ian O Ellis Emad A Rakha Andrew R Green

Breast Cancer Res Treat 2015 Feb 19;150(1):81-90. Epub 2015 Feb 19.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK,

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1007/s10549-015-3306-6	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344553	PMC

February 2015

Biological and clinical significance of PARP1 protein expression in breast cancer.

Authors:

Andrew R Green Daniela Caracappa Ahmed A Benhasouna Alaa Alshareeda Christopher C Nolan R Douglas Macmillan Srinivasan Madhusudan Ian O Ellis Emad A Rakha

Breast Cancer Res Treat 2015 Jan 21;149(2):353-62. Epub 2014 Dec 21.

Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK,

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1007/s10549-014-3230-1	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308637	PMC

January 2015

Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study.

Authors:

Mohammed A Aleskandarany Ola H Negm Andrew R Green Mohamed A H Ahmed Christopher C Nolan Patrick J Tighe Ian O Ellis Emad A Rakha

Breast Cancer Res Treat 2014 Jun 26;145(2):339-48. Epub 2014 Apr 26.

Department of Histopathology, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK,

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1007/s10549-014-2927-5	DOI Listing

June 2014

HER2/HER3 heterodimers and p21 expression are capable of predicting adjuvant trastuzumab response in HER2+ breast cancer.

Authors:

Andrew R Green Fabrício F T Barros Tarek M A Abdel-Fatah Paul Moseley Christopher C Nolan Alice C Durham Emad A Rakha Stephen Chan Ian O Ellis

Breast Cancer Res Treat 2014 May 6;145(1):33-44. Epub 2014 Apr 6.

Molecular Pathology Research Unit, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, NG5 1PB, UK,

View Article

Download full-text PDF	Source
http://link.springer.com/10.1007/s10549-014-2925-7	Publisher Site
http://dx.doi.org/10.1007/s10549-014-2925-7	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984415	PMC

May 2014

Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay.

Authors:

Fabrício F T Barros Tarek M A Abdel-Fatah Paul Moseley Christopher C Nolan Alice C Durham Emad A Rakha Stephen Chan Ian O Ellis Andrew R Green

Breast Cancer Res Treat 2014 Apr 21;144(2):273-85. Epub 2014 Feb 21.

Molecular Pathology Research Unit, Division of Oncology, School of Medicine, Nottingham City Hospital, University of Nottingham, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1007/s10549-014-2871-4	DOI Listing

April 2014

Molecular profiling of breast cancer in Nigerian women identifies an altered p53 pathway as a major mechanism underlying its poor prognosis compared with British counterpart.

Authors:

Ayodeji O J Agboola Adekunbiola A F Banjo Charles C Anunobi Babatunde A Ayoade Anotu Mopelola Deji-Agboola Adewale A Musa T Abdel-Fatah Christopher C Nolan Emad A Rakha Ian O Ellis Andrew R Green

Malays J Pathol 2014 Apr;36(1):3-17

Olabisi Onabanjo University, Department of Morbid Anatomy and Histopathology, Sagamu.

View Article

Download full-text PDF	Source
http://www.mjpath.org.my/2014/v36n1/molecular-profiling-of-b	Web Search

April 2014

SHON is a novel estrogen-regulated oncogene in mammary carcinoma that predicts patient response to endocrine therapy.

Authors:

Yewon Jung Tarek M A Abdel-Fatah Stephen Y T Chan Christopher C Nolan Andrew R Green Ian O Ellis Lili Li Baiqu Huang Jun Lu Bing Xu Longxin Chen Runlin Z Ma Min Zhang Jingru Wang ZhengSheng Wu Tao Zhu Jo K Perry Peter E Lobie Dong-Xu Liu

Cancer Res 2013 Dec;73(23):6951-62

Authors' Affiliations: Liggins Institute, University of Auckland, Auckland, New Zealand; Department of Clinical Oncology; Department of Histopathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom; The Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University; The Institute of Genetics and Cytology, Northeast Normal University, Changchun; Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing; Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China; Department of Pathology, Anhui Medical University, Hefei, China; Cancer Science Institute of Singapore, and Department of Pharmacology, National University of Singapore; and National Cancer Institute of Singapore, National University Health System, Singapore.

View Article

Download full-text PDF	Source
http://cancerres.aacrjournals.org/content/73/23/6951.full.pd	Web Search
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.	Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-13-0982	DOI Listing

December 2013

Poly(adenosine diphosphate-ribose) polymerase expression in BRCA-proficient ovarian high-grade serous carcinoma; association with patient survival.

Authors:

Alex Gan Andrew R Green Christopher C Nolan Stewart Martin Suha Deen

Hum Pathol 2013 Aug 8;44(8):1638-47. Epub 2013 Apr 8.

Department of Histopathology, Nottingham University Hospitals NHS Trust, Queen's Medical Centre Campus, Nottingham, NG7 2UH, UK.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.humpath.2013.01.015	DOI Listing

August 2013

A quantifier-based fuzzy classification system for breast cancer patients.

Authors:

Daniele Soria Jonathan M Garibaldi Andrew R Green Desmond G Powe Christopher C Nolan Christophe Lemetre Graham R Ball Ian O Ellis

Artif Intell Med 2013 Jul 18;58(3):175-84. Epub 2013 Jun 18.

School of Computer Science, Advanced Data Analysis Centre, University of Nottingham, Jubilee Campus, Wollaton Road, Nottingham NG8 1BB, UK.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.artmed.2013.04.006	DOI Listing

July 2013

Cell Proliferation (KI-67) Expression Is Associated with Poorer Prognosis in Nigerian Compared to British Breast Cancer Women.

Authors:

Ayodeji O J Agboola Adekumbiola A F Banjo Charles C Anunobi Babatunde Salami Mopelola Deji Agboola Adewale A Musa Christopher C Nolan Emad A Rakha Ian O Ellis Andrew R Green

ISRN Oncol 2013 11;2013:675051. Epub 2013 Apr 11.

Department of Morbid Anatomy and Histopathology, Olabisi Onabanjo University, Sagamu, Nigeria.

View Article

Download full-text PDF	Source
https://www.hindawi.com/archive/2013/675051/	Publisher Site
http://dx.doi.org/10.1155/2013/675051	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649293	PMC

May 2013

The microRNA maturation regulator Drosha is an independent predictor of outcome in breast cancer patients.

Authors:

Sarkawt M Khoshnaw Emad A Rakha Tarek Abdel-Fatah Christopher C Nolan Zsolt Hodi R Douglas Macmillan Ian O Ellis Andrew R Green

Breast Cancer Res Treat 2013 Jan 6;137(1):139-53. Epub 2012 Dec 6.

Department of Histopathology, School of Molecular Medical Sciences, University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1007/s10549-012-2358-0	DOI Listing

January 2013

TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcome.

Authors:

Mohammed A Aleskandarany Ola H Negm Emad A Rakha Mohamed A H Ahmed Christopher C Nolan Graham R Ball Carlos Caldas Andrew R Green Patrick J Tighe Ian O Ellis

Breast Cancer Res Treat 2012 Nov 4;136(2):419-27. Epub 2012 Oct 4.

Division of Pathology, School of Molecular Medical Sciences, University of Nottingham, Nottingham, United Kingdom.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1007/s10549-012-2249-4	DOI Listing

November 2012

Loss of Dicer expression is associated with breast cancer progression and recurrence.

Authors:

Sarkawt M Khoshnaw Emad A Rakha Tarek M Abdel-Fatah Christopher C Nolan Zsolt Hodi Douglas R Macmillan Ian O Ellis Andrew R Green

Breast Cancer Res Treat 2012 Sep 21;135(2):403-13. Epub 2012 Jul 21.

Department of Histopathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1007/s10549-012-2169-3	DOI Listing

September 2012

Fatty acid binding protein 7 expression and its sub-cellular localization in breast cancer.

Authors:

Alaa T Alshareeda Emad A Rakha Christopher C Nolan Ian O Ellis Andrew R Green

Breast Cancer Res Treat 2012 Jul 6;134(2):519-29. Epub 2012 May 6.

Department of Histopathology and School of Molecular Medical Sciences, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF	Source
http://link.springer.com/10.1007/s10549-012-2083-8	Publisher Site
http://dx.doi.org/10.1007/s10549-012-2083-8	DOI Listing

July 2012

Pathological outcomes in kidney and brain in male Fischer rats given dietary ochratoxin A, commencing at one year of age.

Authors:

Peter G Mantle Christopher C Nolan

Toxins (Basel) 2010 05 13;2(5):1100-10. Epub 2010 May 13.

Centre for Environmental Policy, Imperial College London, London, SW7 2AZ, UK.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.3390/toxins2051100	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153236	PMC

May 2010

Reversible disruption of tight junction complexes in the rat blood-brain barrier, following transitory focal astrocyte loss.

Authors:

Colin L Willis Lopa Leach Garry J Clarke Christopher C Nolan David E Ray

Glia 2004 Oct;48(1):1-13

MRC Applied Neuroscience Group, School of Biomedical Sciences, Queen's Medical Centre, University of Nottingham, NG7 2UH, Nottingham, United Kingdom.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1002/glia.20049	DOI Listing

October 2004

Focal astrocyte loss is followed by microvascular damage, with subsequent repair of the blood-brain barrier in the apparent absence of direct astrocytic contact.

Authors:

Colin L Willis Christopher C Nolan Sharon N Reith Timothy Lister Malcolm J W Prior Christopher J Guerin George Mavroudis David E Ray

Glia 2004 Mar;45(4):325-37

MRC Applied Neuroscience Group, School of Biomedical Sciences, Queens Medical Centre, University of Nottingham, Nottingham, United Kingdom.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1002/glia.10333	DOI Listing

March 2004

Microglial activation and increased synthesis of complement component C1q precedes blood-brain barrier dysfunction in rats.

Authors:

Nicholas J Lynch Colin L Willis Christopher C Nolan Silke Roscher Maxine J Fowler Eberhard Weihe David E Ray Wilhelm J Schwaeble

Mol Immunol 2004 Jan;40(10):709-16

Department of Infection, Immunity and Inflammation, University of Leicester, University Road, Leicester LE1 9HN, UK.

View Article

Download full-text PDF	Source

January 2004

Christopher C Nolan

Christopher C Nolan

Publications by authors named "Christopher C Nolan"

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors:

Download full-text PDF

Authors: